公开(公告)号：EP1487803A1

公开(公告)日：2004-12-22

申请号：EP03744395.9

申请日：2003-03-07

申请人： Aventis Pharma S.A.

发明人： DAMOUR, Dominique ,  CARRY, Jean-Christophe ,  NEMECEK, Patrick ,  TERRIER, Corinne ,  NARDI, Frederico ,  FILOCHE, Bruno ,  CHERRIER, Marie-Pierre ,  BEZARD, Daniel

IPC分类号： C07D231/56 ,  A61K31/416 ,  A61P35/00 ,  C07D409/04 ,  C07D405/04 ,  C07D401/04 ,  C07D471/04 ,  C07D403/12 ,  C07D403/04 ,  C07D401/12 ,  C07D409/12 ,  C07D413/12 ,  C07D413/14

CPC分类号： C07D231/56

摘要： Disclosed are substituted indazoles, compositions containing said substituted indazoles, a production method, and the use thereof. The invention particularly relates to novel specific substituted indazoles having a kinase-inhibiting activity and a therapeutic activity, especially in oncology.